The 2020 National Drug Threat Assessment (NDTA) is a comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generated through illicit drug sales. It also addresses the role domestic groups, including organized violent gangs, serve in domestic drug trafficking. The most widely trafficked drugs are discussed in terms of their availability, consumption and overdose related deaths, production and cultivation, transportation, and distribution.
The report provides strategic analysis of the domestic drug situation during 2019 and the first half of 2020. This assessment is prepared through detailed analysis of the most recent law enforcement, intelligence, and public health data available to counterdrug agencies through the date of publication. To evaluate the threat of illicit drugs, analysts considered quantitative and qualitative information. Qualitative information on seizures, investigations, arrests, laboratory analyses, drug purity or potency, and price were considered. Qualitative information pertaining to the presence and level of domestic and foreign criminal activity, general trends in production or cultivation levels, involvement of organized criminal groups, and other related safety hazards, environmental effects, and associated criminal activity were also considered. The evaluation of the domestic use of illicit drugs was based on accepted data captured in national substance abuse indicators.
This product was prepared by DEA’s Strategic Intelligence Section. Comments and questions may be addressed to the Office of Intelligence Programs at DEA.IntelligenceProducts@usdoj.gov. For media/press inquiries call (571) 776-2508.